Epilepsy

Current Opinion in Neurology

Volumn 20, Issue 2, 2007, Pages 169-174

  Beghi, Ettore ^a,b  

^a SAN GERARDO HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Diagnosis; Epilepsy; Mechanisms; Review; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CONJUGATED ESTROGEN; ETIRACETAM; GLYCOPROTEIN P INHIBITOR; LAMOTRIGINE; LORAZEPAM; MEDROXYPROGESTERONE ACETATE; OXCARBAZEPINE; PARALDEHYDE; PHENYTOIN; TARIQUIDAR; TOPIRAMATE; VALPROIC ACID;

ACCURACY; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITION; CULTURAL ANTHROPOLOGY; DEFENSE MECHANISM; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DIZZINESS; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; FOLLOW UP; GENETICS; HUMAN; MEDICAL RESEARCH; MEMORY; NAUSEA; PHENOTYPE; PREGNANCY; PREVALENCE; PROGNOSIS; REMISSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEIZURE; SOMNOLENCE; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

ANIMALS; COGNITION; EPILEPSY; HUMANS; MEMORY; RISK FACTORS;

EID: 33947170426     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3280d646e4     Document Type: Review

References (48)

1. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005; 46:1724-1743.
2. Heinrichs SC, Seyfried TN. Behavioral seizure correlates in animal models of epilepsy: a road map for assay selection, data interpretation, and the search for causal mechanisms. Epilepsy Behav 2006; 8:5-38. • This review is a guide to rational selection, implementation and interpretation of behavioral data when employing functional correlates of brain activity using animal models of epilepsy.
3. Remy S, Beck H. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain 2006; 129:18-35. •• This review focused on the molecular and cellular abnormalities underlying the two major concepts put forward to explain the development of drug resistance in epilepsy: the transporter and the target hypotheses.
4. Kubota H, Ishihara H, Langmann T, et al. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Epilepsy Res 2006; 68:213-228.
5. Van Vliet EA, van Schaik R, Edelbroek PM, et al. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats. Epilepsia 2006; 47:672-680.
6. Rambeck B, Jurgens UH, May TW, et al. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia 2006; 47:681-694.
7. Loscher W, Schmidt D. Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs. Epilepsia 2006; 47:1253-1284.
8. Berg AT, Kelly MM. Defining intractability: comparisons among published definitions. Epilepsia 2006; 47:431-436.
9. Uldall P, Alving J, Hansen LK, et al. The misdiagnosis of epilepsy in children admitted to a tertiary epilepsy centre with paroxysmal events. Arch Dis Child 2006; 91:219-221.
10. Derry CP, Davey M, Johns M, et al. Distinguishing sleep disorders from seizures: diagnosing bumps in the night. Arch Neurol 2006; 63:705-709.
11. Chung SS, Gerber P, Kirlin KA. Ictal eye closure is a reliable indicator for psychogenic nonepileptic seizures. Neurology 2006; 66:1730-1731.
12. Choi H, Winawer MR, Kalachikov S, et al. Classification of partial seizure symptoms in genetic studies of the epilepsies. Neurology 2006; 66:1648-1653.
13. Oka E, Ohtsuka Y, Yoshinaga H, et al. Prevalence of childhood epilepsy and distribution of epileptic syndromes: a population-based survey in Okayama, Japan. Epilepsia 2006; 47:626-630.
14. Sadleir LG, Farrell K, Smith C, et al. Electroclinical features of absence seizures in childhood absence epilepsy. Neurology 2006; 67:413-418.
15. Helpelmann A, Taylor KP, Heils A, et al. Exploration of the genetic architecture of idiopathic generalized epilepsies. Epilepsia 2006; 47:1682-1690. • This study of multiplex families of European descent collected from one Australian and six European research groups revealed evidence for complex and heterogeneous genetic architectures, consistent with heterogeneous configurations of susceptibility loci associated with different idiopathic generalized epilepsy subtypes.
16. Martinez-Juarez IE, Alonso ME, Medina MT, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain 2006; 129:1269-1280. • The prospective investigation of a large cohort of patients with JME showed it as the sole phenotype in 40% of families, which is in support of a distinct and separate entity.
17. Galitto G, Serra S, La Spina P, et al. Prevalence and characteristics of epilepsy in the Aeolian islands. Epilepsia 2005; 46:1828-1835.
18. Rocca WA, Savettieri G, Anderson DW, et al., for the Sicilian Neuro Epidemiologic Study (SNES) Group. Door-to door prevalence survey of epilepsy in three Sicilian municipalities. Neuroepidemiology 2001; 20:237-241.
19. Mohammadi MR, Ghanizadeh A, Davidian H, et al. Prevalence of epilepsy and comorbidity of psychiatric disorders in Iran. Seizure 2006; 15:476-482.
20. Chen CC, Chen T-F, Hwang Y-C, et al. Population-based survey on prevalence of adult patients with epilepsy in Taiwan (Keelung community-based integrated screening no. 12). Epilepsy Res 2006; 72:67-74.
21. Chin RF, Neville BG, Peckham C, et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet 2006; 368:222-229. • This is the first prospective population-based study of the incidence, determinants, and short-term outcome of status epilepticus primarily in children. The study shows that status epilepticus in childhood is common and has features that make it distinct from the condition in adulthood.
22. Hesdorffer DC, Logroscino G, Cascino G, et al. Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. Neurology 1998; 50:735-741.
23. Coeytaux A, Jallon P, Galobardes B, Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 2000; 55:693-697.
24. Knake S, Rosenow F, Vescovi M, et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 2001; 42:714-718.
25. Amatniek JC, Hauser WA, DelCastillo-Castaneda C, et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006; 47:867-872.
26. Whitehead E, Dodds L, Joseph KS, et al. Relation of pregnancy and neonatal factors to subsequent development of childhood epilepsy: a population-based cohort study. Pediatrics 2006; 117:1298-1306. •• In a large, population-based cohort with extensive clinical information, the authors found a number of pregnancy and neonatal risk factors for epilepsy, supporting the concept that prenatal factors contribute to the occurrence of childhood epilepsy.
27. Tellez-Zenteno JF, Matijevic S, Wibe S. Somatic comorbidity of epilepsy in the general population in Canada. Epilepsia 2005; 46:1955-1962.
28. Sillanpaa M, Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 2006; 129:617-624.
29. Holmes GL, Lenck-Santini PP. Role of interictal epileptiform abnormalities in cognitive impairment. Epilepsy Behav 2006; 8:504-515. • This review provides evidence supporting the suggestion that frequent and widespread interictal spikes can impair cognitive abilities by interfering with waking learning and memory, and with memory consolidation during sleep.
30. Alpherts WC, Vermeulen J, van Rijen PC, et al. Verbal memory decline after temporal epilepsy surgery?: a 6-year multiple assessments follow-up study. Neurology 2006; 67:626-631.
31. Araujo D, Santos AC, Velasco TR, et al. Volumetric evidence of bilateral damage in unilateral mesial temporal lobe epilepsy. Epilepsia 2006; 47:1354-1359.
32. Gross DW, Concha L, Beaulieu C. Extratemporal white matter abnormalities in mesial temporal lobe epilepsy demonstrated with diffusion tensor imaging. Epilepsia 2006; 47:1360-1363.
33. Hermann B, Jones J, Sheth R, et al. Children with new-onset epilepsy: neuropsychological status and brain structure. Brain 2006; 129:2609-2619.
34. Stephen LJ, Kelly K, Mohanraj R, Brodie MJ. Pharmacological outcomes in older people with newly diagnosed epilepsy. Epilepsy Behav 2006; 8:434-437.
35. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999; 37:81-87.
36. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 1995; 345:476-479.
37. EURAP Study Group. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. Neurology 2006; 66:354-360.
38. Biton V, Sackellares JC, Vuong A, et al. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 2005; 65:1737-1743.
39. Glauser TA, Ayala R, Elterman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006; 66:1654-1660.
40. Ahmad S, Ellis JC, Kamwendo H, Molyneux E. Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. Lancet 2006; 367:1591-1597. • The study highlights the efficacy, safety and ease of use of a fairly inexpensive drug in a tertiary hospital from a developing country.
41. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006; 67:340-342.
42. Gamble C, Williamson PR, Chadwick DW, Marson AG. A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Neurology 2006; 66:1310-1317.
43. Blum D, Meador K, Biton V, et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology 2006; 67:400-406.
44. Harden CL, Pulver MC, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999; 40:1402-1407.
45. Harden CL, Herzog AG, Nikolov BG, et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia 2006; 47:1447-1451.
46. Pohlmann-Eden B, Beghi E, Camfield C, Camfield P. The first seizure and its management in adults and children. BMJ 2006; 332:339-342.
47. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 47:1094-1120. • This is a systematic review of the best available evidence on the effectiveness of drugs as initial monotherapy for different epileptic seizures and syndromes.
48. Riviello JJ Jr, Ashwal S, Hirtz D, et al. Practice parameter: diagnostic assessment of the child with status epilepticus (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2006; 67:1542-1550.